Results for blood to plasma ratio translation from English to Maltese

distribution the blood-to-plasma ratio of nilotinib is 0.71.
distribuzzjoni il- proporzjon tad- demm- għal- plażma ta ’ imatinib huwa 0. 71.

nintedanib is preferentially distributed in plasma with a blood to plasma ratio of 0.869.
nintedanib jiġi ddistribwit b'mod preferenzjali fil-plażma bi proporzjon ta' demm għal plażma ta' 0.869.

tissue to plasma ratios of
56 studji fuq id- distribuzzjoni fit- tessuti b’ ritonavir tikkettat 14c li saru fuq il- firien, urew li l- fwied, l - adrenali, il- frixa, il- kliewi u t- tirojde kellhom l- ogħla konċentrazzjoni ta ’ ritonavir.

8-fold compared to plasma).
konċentrazzjonijiet għolja fit- tessut tal- moħħ kienu osservati fil- firien (madwar 8 darbiet aktar meta mqabbel mal- plażma).

cinacalcet is excreted in the milk of lactating rats with a high milk to plasma ratio.
cinacalcet joħroġ fil-ħalib ta’ firien li jreddgħu bi proporzjon ta’ ħalib għall-plażma għoli.

the mean plasma to blood concentration ratio was approximately 1.0 and the mean semen to plasma concentration ratio was approximately 4.0.
il-proporzjon tal-konċentrazzjoni medja tal-plażma għad-demm kienet madwar 1.0 u l-proporzjon tal-konċentrazzjoni medja semen għal plażma kienet madawar 4.0.

studies with abacavir demonstrate a csf to plasma auc ratio of between 30 to 44%.
studji dwar abacavir juru l-proporzjon tas-csf ma’ l-auc fil-plażma ta’ bejn 30 sa 44%.

the blood to plasma ratio (b/p) of 36 indicates that sirolimus is extensively partitioned into formed blood elements.
il-proporzjon fid-demm mal-plażma (b/p) ta’ 36 jindika li sirolimus huwa mqassam estensivament ġol-elementi ffurmati tad-demm.

medicinal products highly bound to plasma protein
prodotti mediċinali li jingħaqdu b’qawwa ma’ proteina fil-plażma

tolvaptan binds reversibly (98%) to plasma proteins.
tolvaptan jeħel b’mod riversibbli (98%) mal-proteini tal-plażma.

after a single 400 mg dose of [14c]-sofosbuvir in healthy subjects, the blood to plasma ratio of 14c-radioactivity was approximately 0.7.
wara doża waħda ta’ 400 mg ta’ [14c]-sofosbuvir f’individwi b’saħħithom, il-proporzjon tad-demm mal-plażma ta’ radjuattività 14c kien ta’ madwar 0.7.

at peak plasma concentration, the mean plasma to blood drug concentration ratio was ~1.0 and the mean semen to plasma drug concentration ratio was ~4.0.
f’konċentrazzjoni massima fil-plażma, il-medja tal-proporzjon tal-konċentrazzjoni tal-mediċina fil-plażma mqabbla ma’ dik fid-demm kienet ta’ ~1.0 u l-medja tal-proporzjon tal-konċentrazzjoni fil-plażma mqabbla ma’ dik fis-semen kienet ta’ ~4.0.

after a single 400 mg dose of [14c]-sofosbuvir in healthy subjects, the blood to plasma ratio of [14c]-radioactivity was approximately 0.7.
wara doża waħda ta’ 400 mg ta’ [14c]-sofosbuvir f’individwi b’saħħithom, il-proporzjon tad-demm mal-plażma ta’ [14c]-radjuattività kien ta’ madwar 0.7.

in vitro, the lenvatinib blood-to-plasma concentration ratio ranged from 0.589 to 0.608 (0.1 – 10 μg/ml, mesilate).
in vitro, il-proporzjon tal-konċentrazzjoni ta’ lenvatinib fid-demm u fil-plażma varja minn 0.589 sa 0.608 (0.1 - 10 μg/ml, mesilate).

the distribution of ambrisentan into red blood cells is low, with a mean blood: plasma ratio of 0.57 and 0.61 in males and females, respectively.
id- distribuzzjoni ta 'ambrisentan f' ċelloli ħomor tad- demm hi baxxa, b' medja proporzjonali demm: plażma ta' 0. 57 u 0. 61 f' nisa u rġiel rispettivament.

after a single 90 mg dose of [14c]-ledipasvir in healthy subjects, the blood to plasma ratio of [14c]-radioactivity ranged between 0.51 and 0.66.
wara doża waħda ta’ 90 mg ta’ [14c]-ledipasvir f’individwi b’saħħithom, il-proporzjon tad-demm għall-plażma ta’ [14c]-radjuattività jvarja bejn 0.51 u 0.66.

in an in vitro study, zoledronic acid showed low affinity for the cellular components of human blood, with a mean blood to plasma concentration ratio of 0.59 in a concentration range of 30 ng/ml to
fi studju in vitro, zoledronic acid ma wera affinità baxxa għall-komponenti ċellulari tad-demm uman, bil-demm medja għal proporzjon tal-konċentrazzjoni fil-plażma ta’ 0.59 fil-medda ta’ konċentrazzjoni ta’ 30 ng/ml sa 5000 ng/ml.

the blood to plasma concentration ratios in human ranged from 0.5 to 0.7 indicating that dasabuvir was preferentially distributed in the plasma compartment of whole blood.
il-proporzjoni ta’ demm għal konċentrazzjoni tal-plażma fil-bnedmin varjat minn 0.5 għal 0.7 li tindika li dasabuvir kien mqassam b’mod preferenzjali fil-kompartiment tal-plażma tad-demm sħiħ.

difloxacin is well distributed throughout the animal body, as was demonstrated by the tissue to plasma ratios.
difloxacin jitqassam sew fil-ġisem kollu kif kien muri bil-proporzjon li jinstab fit-tessuti u fil-plażma.

bivalirudin does not bind to plasma proteins (other than thrombin) or to red blood cells.
bivalirudin ma jeħilx mal-proteini tal-plażma (għajr it-thrombin) jew maċ- ċelloli ħomor tad-demm.